Applied Clinical Trials
The latest eclinical software in the clinical trials industry.
Standalone software supports popular content management systems
Octagon Research Solutions (Wayne, PA) announced ViewPoint Connect Module. The standalone software supports connectivity to content management systems including EMC's Documentum 6; OpenText Livelink 9.7.1; Oracle Content DB 10.2; and Microsoft SharePoint 3.0. ViewPoint Connector is also available as a module to the company's flagship process management solution, ViewPoint, which accesses content management systems for managing and controlling content-driven enterprise processes such as global regulatory submissions.
ViewPoint Connector is a layer that sits over proprietary API toolkits to provide a single unified access point to pieces of content and metadata across various repositories.
Octagon Research Solutions, (610) 535-6500, www.octagonresearch.com
Software adds features to increase research site productivity
Bio-Optronics (Rochester, NY) has enhanced its Clinical Conductor Site Clinical Trial Management System (CTMS) to include increased patient database function, improved QuickBooks integration, and updated financial management and reporting. Also updated is its patient Virtual Recruitment and Business Development modules.
The Web-based Virtual Recruiter enables sites to use the Web to prequalify potential study participants. Screening questions are highly configurable to the desired level of detail. The Business Development solution provides full tracking and management of trial opportunities and actions. Both modules integrate with Clinical Conductor. The company is also cross-marketing and integrating its CTMS with flexcipio's eClinical Electronic Data Capture solution.
Bio-Optronics, (585) 272-1960, www.bio-optronics.com
EDC and CTMS now offers more powerful data mining
Nextrials (San Ramon, CA) announced its Prism data capture and clinical trial management platform has increased its report generation function to deliver more powerful data mining capabilities to customers. With the improved ad hoc reporting feature, users can now collect, summarize, and export data from tables within a single study or across multiple studies.
Its user-friendly graphical interface also includes advanced interactive data view formats, such as heat maps, in addition to bar graphs, pie charts, and other standard visual templates. It also includes preview panes to help users visualize reports in progress; enhanced export capabilities; and concomitant medication and adverse event coding data integration.
Nextrials, (925) 355-3000, www.nextrials.com
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
STEP UP Trial Shows Semaglutide 7.2 mg Achieves Superior Weight Loss vs. 2.4 mg, Placebo
January 17th 2025Semaglutide 7.2 mg significantly outperformed semaglutide 2.4 mg and placebo with a 20.7% average reduction in weight and a comparable safety and tolerability profile, further establishing its efficacy in obesity treatment.